Business Context and Reporting Period
This Form 8-K Current Report from LIFECORE BIOMEDICAL, INC. (LFCR) covers events occurring on June 4, 2026, specifically the Company's 2026 Annual Meeting of Stockholders. The filing details the election of directors, the ratification of auditors, and the approval of executive compensation and a new stock incentive plan.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metrics.
Material Changes and Corporate Actions
- Stock Incentive Plan Approval: Stockholders approved the 2026 Stock Incentive Plan. The plan will become effective on October 16, 2026, replacing the expiring 2019 Plan. It authorizes the issuance of 2,500,000 shares of Common Stock, plus shares from forfeited or expired awards under the prior plan.
- Director Elections: Nine directors were elected to serve until the 2027 Annual Meeting.
- 7 Directors were elected by Common Stock and Series A Preferred Stockholders voting together (including Katrina L. Houde, Humberto C. Antunes, Paul H. Johnson, Paul Josephs, Matthew E. Korenberg, Nelson Obus, and Joshua E. Schechter).
- 2 Directors (Jason Aryeh and Christopher S. Kiper) were elected solely by Series A Preferred Stockholders.
- Auditor Ratification: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026.
- Executive Compensation: Stockholders approved a non-binding advisory proposal regarding the compensation of named executive officers.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of specific risks or contingencies beyond the standard incorporation by reference of the 2026 Plan terms. The primary focus is the successful execution of the Annual Meeting agenda.
Key Facts for Investor Verification
- Verify the 2,500,000 share reserve for the new 2026 Stock Incentive Plan and its effective date of October 16, 2026.
- Confirm the composition of the Board of Directors, noting the specific election of two directors by Series A Preferred Stockholders.
- Review the voting results for the "Say-on-Pay" proposal, which received strong support (22,938,684 votes for vs. 178,868 against).
- Note the total voting power represented at the meeting was equivalent to 45,017,850 shares of Common Stock (including as-converted Series A Preferred Stock).